Nasal Spray Diuretic Shows Potential for Heart Failure in Trial of Healthy Adults

Watchdoq November 19, 2024
(MedPage Today) -- CHICAGO -- A bumetanide nasal spray in development for heart failure was well-tolerated and showed reliable rates of absorption compared with oral and intravenous delivery in a phase I trial of healthy volunteers.
The 68-person...

Read Full Article